RxDoctor Payments Data

Ahmed Buksh, DPM

Podiatrist · Edmond, OKNPI 1457308736

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.3%), education and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Pylant Medical at 30.4% of the total. Reporting peaked in 2019 at $3,770 and has fallen 69.4% since, to $1,152 in 2025. Among podiatrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,217in general payments, 2019–2025

Across 182 payments — averaging $94.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pylant Medical$5K
  • Amniox Medical, Inc.$4K
  • Axogen$3K
  • Amgen$1K
  • Biotissue Holdings Inc.$964
  • Smith+Nephew$709
  • plus $2K from 15 others

What the payments were for

  • Consulting fees$2,45014%
  • Speaking & faculty fees$7004%
  • Travel & lodging$1,4398%
  • Food & beverage$7,45743%
  • Education$5,17230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,217 in reported general payments places this provider in the 95th percentile of 54 podiatrist providers in Oklahoma.

See all podiatrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$242,354
Medicare patients
342
Services billed
3,596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin96$1,469
Ketoconazole16$411
Ammonium Lactate17$367
Cephalexin24$222
Allopurinol17$182
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$107
Silver Sulfadiazine12$99
SsdSilver Sulfadiazine14$91
Cyclobenzaprine Hcl17$56

Paid to pharmacies, not to this prescriber.

Other podiatrist in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →